跳至主要内容
临床试验/NCT06974994
NCT06974994招募中不适用

Resilience to Antibiotic-induced Obesogenic Microbiota Vertically Transferred to the Neonatal Gut: Discovering Mechanism of Microbiota Modulation

Turku University Hospital1 个研究点 分布在 1 个国家目标入组 125 人开始时间: 2024年5月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
125
试验地点
1
主要终点
BMI at 24 months of age

研究概览

简要总结

The aim is to study whether the microbiota of children who are exposed to antibiotics at birth could be modified by synbiotic supplement and thereby reduce the risk of obesity, chronic diseases and respiratory tract infections. A total of 125 mother-child pairs will be recruited in this randomized, double-blind, placebo-controlled study. Infants are randomized to receive either a synbiotic supplement or a placebo for 2 months, after which their growth and morbidity will be monitored at the research clinic for 2 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
2 Hours 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Pregnant women (n=125) and their newborn children who receive antibiotic treatment at delivery.

排除标准

  • •Chorioamnionitis
  • •Pre-eclampsia and hepatogestosis
  • •Suspected malformation or serious condition of the foetus and neonates
  • •Serious infection or other conditions not permitting breast milk feeding

研究组 & 干预措施

Synbiotic

Active Comparator

Bifidobacterium bifidum and human milk oligosaccharides (HMOs)

干预措施: Synbiotic Supplement (Dietary Supplement)

Placebo

Placebo Comparator

干预措施: Placebo (Other)

结局指标

主要结局

BMI at 24 months of age

时间窗: From enrollment to 24 months of age

Child's body mass index (BMI) at the age of 24 months

次要结局

  • Mother's microbiome(From enrollment to 6 months after giving birth)
  • Respiratory tract infections(From enrollment to 24 months of age)
  • Height(From enrollment to 24 months of age)
  • Breast milk microbiome(From enrollment to 6 months of age)
  • Weight(From enrollment to 24 months of age)
  • Growth velocity(From enrollment to 3 months of age)
  • Inflammatory markers(From enrollment to 6 months of age)
  • Child's microbiome(From enrollment to 24 months of age)
  • Hormonal levels(From enrollment to 6 months of age)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Erika Isolauri

Professor of Paediatrics

Turku University Hospital

研究点 (1)

Loading locations...

相似试验